$AYTU
AYTU BIOPHARMA, INC

2023 Q4 Form 10-Q Financial Statement

#000155837023019015 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $22.93M $22.10M
YoY Change -12.73% -20.09%
Cost Of Revenue $6.731M $7.315M
YoY Change -25.09% -23.98%
Gross Profit $16.20M $14.78M
YoY Change -6.3% -18.01%
Gross Profit Margin 70.65% 66.9%
Selling, General & Admin $12.02M $14.38M
YoY Change -35.33% -17.48%
% of Gross Profit 74.15% 97.25%
Research & Development $524.0K $604.0K
YoY Change -69.36% -43.23%
% of Gross Profit 3.23% 4.09%
Depreciation & Amortization $300.0K $2.230M
YoY Change -25.0% -4.21%
% of Gross Profit 1.85% 15.08%
Operating Expenses $13.84M $16.29M
YoY Change -42.54% -17.26%
Operating Profit $2.364M -$1.504M
YoY Change -134.8% -9.01%
Interest Expense -$1.756M -$6.620M
YoY Change -1856.0% 501.82%
% of Operating Profit -74.28%
Other Income/Expense, Net -$1.179M -$6.616M
YoY Change -1279.0% 438.76%
Pretax Income $608.0K -$8.120M
YoY Change -109.08% 181.85%
Income Tax $828.0K $0.00
% Of Pretax Income 136.18%
Net Earnings -$200.0K -$8.100M
YoY Change -97.01% 181.15%
Net Earnings / Revenue -0.87% -36.65%
Basic Earnings Per Share -$0.04 -$1.48
Diluted Earnings Per Share -$0.04 -$1.48
COMMON SHARES
Basic Shares Outstanding 5.567M 5.530M
Diluted Shares Outstanding 5.482M

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $19.53M $20.00M
YoY Change 0.14% -16.01%
Cash & Equivalents $19.53M $19.96M
Short-Term Investments
Other Short-Term Assets $1.333M $749.0K
YoY Change 113.62% -4.59%
Inventory $13.00M $12.97M
Prepaid Expenses $8.105M $7.038M
Receivables $29.40M $29.90M
Other Receivables $0.00 $0.00
Total Short-Term Assets $71.37M $70.60M
YoY Change 1.08% -5.13%
LONG-TERM ASSETS
Property, Plant & Equipment $1.127M $4.200M
YoY Change -77.55% -25.64%
Goodwill
YoY Change
Intangibles $55.71M $57.34M
YoY Change -14.27% -17.03%
Long-Term Investments
YoY Change
Other Assets $907.0K $772.0K
YoY Change 10.48% -6.88%
Total Long-Term Assets $59.88M $62.29M
YoY Change -15.46% -17.59%
TOTAL ASSETS
Total Short-Term Assets $71.37M $70.60M
Total Long-Term Assets $59.88M $62.29M
Total Assets $131.2M $132.9M
YoY Change -7.2% -11.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.47M $27.50M
YoY Change -46.88% 87.5%
Accrued Expenses $43.41M $40.73M
YoY Change 5.33% -1.69%
Deferred Revenue
YoY Change
Short-Term Debt $1.026M $1.215M
YoY Change -86.19% -84.98%
Long-Term Debt Due $39.00K $100.0K
YoY Change -56.67% -89.19%
Total Short-Term Liabilities $64.19M $65.46M
YoY Change -4.41% -10.57%
LONG-TERM LIABILITIES
Long-Term Debt $14.98M $14.80M
YoY Change 3.06% 9.14%
Other Long-Term Liabilities $6.344M $8.106M
YoY Change -35.14% -13.12%
Total Long-Term Liabilities $34.21M $8.106M
YoY Change 249.75% -13.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.19M $65.46M
Total Long-Term Liabilities $34.21M $8.106M
Total Liabilities $98.40M $100.7M
YoY Change 2.9% 4.82%
SHAREHOLDERS EQUITY
Retained Earnings -$312.5M -$312.2M
YoY Change 6.11% 7.14%
Common Stock $1.000K $344.4M
YoY Change -100.0% -0.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $32.85M $32.17M
YoY Change
Total Liabilities & Shareholders Equity $131.2M $132.9M
YoY Change -7.2% -11.41%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$200.0K -$8.100M
YoY Change -97.01% 181.15%
Depreciation, Depletion And Amortization $300.0K $2.230M
YoY Change -25.0% -4.21%
Cash From Operating Activities -$136.0K -$200.0K
YoY Change -94.43% -97.8%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$170.0K $76.00K
YoY Change 3300.0% -280.95%
Cash From Investing Activities -$170.0K -$76.00K
YoY Change 3300.0% -280.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -130.0K -2.734M
YoY Change -93.03% -120.17%
NET CHANGE
Cash From Operating Activities -136.0K -200.0K
Cash From Investing Activities -170.0K -76.00K
Cash From Financing Activities -130.0K -2.734M
Net Change In Cash -436.0K -3.021M
YoY Change -89.88% -167.87%
FREE CASH FLOW
Cash From Operating Activities -$136.0K -$200.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2023Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2022Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2023Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#ProductMember
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent
CY2023Q2 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q3 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2023Q2 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001385818
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
001-38247
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
AYTU BIOPHARMA, INC.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-0883144
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
7900 East Union Avenue
CY2023Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 920
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80237
CY2023Q3 dei City Area Code
CityAreaCode
720
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
437-6580
CY2023Q3 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2023Q3 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2023Q3 dei Trading Symbol
TradingSymbol
AYTU
CY2023Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5567490
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19964000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22985000
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29882000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
28937000
CY2023Q3 us-gaap Inventory Net
InventoryNet
12966000
CY2023Q2 us-gaap Inventory Net
InventoryNet
11995000
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7038000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8047000
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
749000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
868000
CY2023Q3 us-gaap Assets Current
AssetsCurrent
70599000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
72832000
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1722000
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1815000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2454000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2054000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
57341000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58970000
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
772000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
792000
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
62289000
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
63631000
CY2023Q3 us-gaap Assets
Assets
132888000
CY2023Q2 us-gaap Assets
Assets
136463000
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
14466000
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
13478000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40730000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46799000
CY2023Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
1215000
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
1563000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
62000
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
85000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8990000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7090000
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
65463000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
69015000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14842000
CY2023Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14713000
CY2023Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
12310000
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
6403000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8106000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6975000
CY2023Q3 us-gaap Liabilities
Liabilities
100721000
CY2023Q2 us-gaap Liabilities
Liabilities
97106000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5530235
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5530235
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5517174
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5517174
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
1000
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
344415000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
343485000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-312249000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-304129000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
32167000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
39357000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
132888000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136463000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22099000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27655000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7315000
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9623000
CY2023Q3 us-gaap Gross Profit
GrossProfit
14784000
CY2022Q3 us-gaap Gross Profit
GrossProfit
18032000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
7422000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10102000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6956000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7322000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
604000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1064000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1306000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1197000
CY2022Q3 aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
-155000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
16288000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
19840000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1504000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1808000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-709000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1084000
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5907000
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2191000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6616000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1107000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8120000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-701000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8120000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-701000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5482037
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5482037
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2517906
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2517906
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.48
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.48
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39357000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
930000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8120000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
32167000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
44308000
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1177000
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3564000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-701000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
48348000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-8120000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-701000
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2230000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2301000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
930000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1177000
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-5907000
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2191000
CY2023Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
148000
CY2022Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
145000
CY2022Q3 aytu Contingent Consideration And Contingent Value Rights Gain Loss For Change In Fair Value During Period
ContingentConsiderationAndContingentValueRightsGainLossForChangeInFairValueDuringPeriod
-155000
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
51000
CY2022Q3 us-gaap Inventory Write Down
InventoryWriteDown
82000
CY2023Q3 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-6000
CY2022Q3 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-33000
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
945000
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6212000
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1023000
CY2023Q3 us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2104000
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1125000
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1801000
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
914000
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3587000
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5166000
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3481000
CY2023Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-3744000
CY2022Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
72000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-211000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9148000
CY2023Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
76000
CY2022Q3 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-42000
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76000
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
42000
CY2022Q3 aytu Proceeds From Issuance Of Common Stock And Warrants Net Of Issuance Costs
ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts
10416000
CY2023Q3 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-348000
CY2022Q3 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
4274000
CY2023Q3 aytu Payments For Fixed Payment Arrangement
PaymentsForFixedPaymentArrangement
2204000
CY2022Q3 aytu Payments For Fixed Payment Arrangement
PaymentsForFixedPaymentArrangement
301000
CY2023Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
160000
CY2022Q3 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
793000
CY2023Q3 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
22000
CY2022Q3 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
26000
CY2022Q3 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-13000
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2734000
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13557000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3021000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4451000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22985000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19360000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19964000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23811000
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
1359000
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
565000
CY2022Q3 aytu Warrants Issued
WarrantsIssued
5953000
CY2022Q3 us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
146000
CY2022Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20000000.0
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29900000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-8100000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-700000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-312200000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-304100000
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-200000
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9100000
CY2023Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Prior Period Reclassification</span>. Certain prior year amounts in the consolidated statements of operations have been reclassified to conform to the current year presentation, including a reclassification of the fair value adjustment from contingent considerations. Net gain or loss from the fair value of contingent considerations was previously included in Other Expense, net, and is currently recorded in operating expenses on the consolidated statements of operations. This reclassification did not impact net loss or cash flows for the three months ended September 30, 2023 and 2022 or the Company’s financial position as of September 30, 2023 or June 30, 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:1pt;margin:0pt;"> </p>
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Management uses estimates and assumptions relating to reporting amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, revenue recognition, allowance for credit losses, determination of variable consideration for accruals of chargebacks, administrative fees and rebates, government rebates, returns and other allowances, write-downs for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, income tax provision, deferred taxes and valuation allowance, determination of right-of-use assets and lease liabilities, the depreciable lives of long-lived assets, classification of warrants equity versus liability, and the valuation of warrants and derivative warrant liability. Because of the uncertainties inherent in such estimates, actual results may differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for reasonableness. </p>
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22099000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27655000
CY2022Q3 us-gaap Inventory Write Down
InventoryWriteDown
100000
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
100000
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1968000
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1301000
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3288000
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2956000
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7710000
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
7738000
CY2023Q3 us-gaap Inventory Net
InventoryNet
12966000
CY2023Q2 us-gaap Inventory Net
InventoryNet
11995000
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
5712000
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
5496000
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3990000
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3681000
CY2023Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1722000
CY2023Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
1815000
CY2022Q3 us-gaap Depreciation
Depreciation
300000
CY2023Q3 us-gaap Depreciation
Depreciation
300000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
360000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
222000
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
23000
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
160000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
14000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
18000
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
3000
CY2023Q3 us-gaap Lease Cost
LeaseCost
398000
CY2022Q3 us-gaap Lease Cost
LeaseCost
403000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2454000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2054000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
159000
CY2023Q3 aytu Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
2454000
CY2023Q2 aytu Operating Lease And Finance Lease Right Of Use Asset
OperatingLeaseAndFinanceLeaseRightOfUseAsset
2213000
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1265000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1258000
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
62000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
85000
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1208000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
832000
CY2023Q3 aytu Operating Lease And Finance Lease Liability
OperatingLeaseAndFinanceLeaseLiability
2535000
CY2023Q2 aytu Operating Lease And Finance Lease Liability
OperatingLeaseAndFinanceLeaseLiability
2175000
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y7M24D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y8M19D
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y7M13D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y10M13D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0860
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0778
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0654
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0654
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
360000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
357000
CY2023Q3 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1000
CY2022Q3 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
3000
CY2023Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
23000
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
27000
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1035000
CY2023Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
64000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
937000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
282000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
241000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
199000
CY2023Q3 aytu Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
168000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2862000
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
64000
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
389000
CY2023Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
2000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2473000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
62000
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
78583000
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
78583000
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21242000
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
57341000
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
81558000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19613000
CY2023Q2 aytu Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
2975000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
58970000
CY2023Q2 aytu Indefinite Lived Intangible Assets Excluding Goodwill Before Accumulated Impairment
IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeAccumulatedImpairment
2600000
CY2023Q2 aytu Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment
2600000
CY2023Q2 aytu Indefinite Lived Intangible Assets Excluding Goodwill Before Accumulated Impairment
IndefiniteLivedIntangibleAssetsExcludingGoodwillBeforeAccumulatedImpairment
2600000
CY2023Q2 aytu Indefinite Lived Intangible Assets Excluding Goodwill Accumulated Impairment
IndefiniteLivedIntangibleAssetsExcludingGoodwillAccumulatedImpairment
2600000
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
84158000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
19613000
CY2023Q2 aytu Intangible Assets Net Excluding Goodwill Accumulated Impairment
IntangibleAssetsNetExcludingGoodwillAccumulatedImpairment
5575000
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58970000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
4889000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
4989000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
4989000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4989000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
4988000
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
32497000
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
57341000
CY2023Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1600000
CY2022Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
1500000
CY2023Q3 aytu Accrued Saving Offers
AccruedSavingOffers
13023000
CY2023Q2 aytu Accrued Saving Offers
AccruedSavingOffers
15739000
CY2023Q3 aytu Accrued Program Related Liabilities
AccruedProgramRelatedLiabilities
9994000
CY2023Q2 aytu Accrued Program Related Liabilities
AccruedProgramRelatedLiabilities
11012000
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5374000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5675000
CY2023Q3 aytu Accrued Customer And Product Related Fees Current
AccruedCustomerAndProductRelatedFeesCurrent
4691000
CY2023Q2 aytu Accrued Customer And Product Related Fees Current
AccruedCustomerAndProductRelatedFeesCurrent
6579000
CY2023Q3 aytu Return Reserve Current
ReturnReserveCurrent
5137000
CY2023Q2 aytu Return Reserve Current
ReturnReserveCurrent
5777000
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2511000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2017000
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40730000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
46799000
CY2023Q3 aytu Fixed Payment Arrangements
FixedPaymentArrangements
9380000
CY2023Q2 aytu Fixed Payment Arrangements
FixedPaymentArrangements
10420000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2473000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2090000
CY2023Q3 aytu Employee Retention Credit
EmployeeRetentionCredit
3759000
CY2023Q3 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
1484000
CY2023Q2 us-gaap Other Sundry Liabilities
OtherSundryLiabilities
1555000
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
17096000
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
14065000
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8990000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
7090000
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8106000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6975000
CY2023Q3 aytu Proceeds From Employee Retention Credit Program
ProceedsFromEmployeeRetentionCreditProgram
3800000
CY2023Q3 aytu Employee Retention Credit Vendor Fee
EmployeeRetentionCreditVendorFee
400000
CY2022Q1 us-gaap Share Price
SharePrice
25.00
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
15000000
CY2023Q3 us-gaap Debt Instrument Fee Amount
DebtInstrumentFeeAmount
638000
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
796000
CY2023Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
62000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
14904000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
62000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14842000
CY2023Q3 aytu Long Term Debt And Finance Lease Liability Maturity Year One
LongTermDebtAndFinanceLeaseLiabilityMaturityYearOne
62000
CY2023Q3 aytu Long Term Debt And Finance Lease Liability Maturity Year Two
LongTermDebtAndFinanceLeaseLiabilityMaturityYearTwo
15638000
CY2023Q3 aytu Long Term Debt And Finance Lease Liability Gross
LongTermDebtAndFinanceLeaseLiabilityGross
15700000
CY2023Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
796000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
62000
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
14842000
CY2023Q3 aytu Number Of Monte Carlo Simulations
NumberOfMonteCarloSimulations
100000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5530235
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5517174
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
52762
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
18.37
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y21D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
112000
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.73
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2045
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.78
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
34
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
158.09
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
162683
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.91
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y6M18D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3019
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
227.16
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y11M19D
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
112000
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.73
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
300000
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y8M12D
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1808000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1855000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1177000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
930000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1177000
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6750854
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1784184
CY2023Q3 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
22099000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1504000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1941000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
930000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
27655000

Files In Submission

Name View Source Status
aytu-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001558370-23-019015-index-headers.html Edgar Link pending
0001558370-23-019015-index.html Edgar Link pending
0001558370-23-019015.txt Edgar Link pending
0001558370-23-019015-xbrl.zip Edgar Link pending
aytu-20230930.xsd Edgar Link pending
aytu-20230930x10q.htm Edgar Link pending
aytu-20230930x10q001.jpg Edgar Link pending
aytu-20230930xex31d1.htm Edgar Link pending
aytu-20230930xex31d2.htm Edgar Link pending
aytu-20230930xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
aytu-20230930_def.xml Edgar Link unprocessable
aytu-20230930_lab.xml Edgar Link unprocessable
aytu-20230930_pre.xml Edgar Link unprocessable
aytu-20230930x10q_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending